← Browse by Condition
Medical Condition
ulcerative colitis
Total Trials
23
Recruiting Now
23
Trial Phases
Phase 4, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for ulcerative colitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — ulcerative colitis Clinical Trials
How many clinical trials are currently recruiting for ulcerative colitis?
ClinicalMetric currently tracks 23 actively recruiting clinical trials for ulcerative colitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 23. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ulcerative colitis?
ulcerative colitis research spans Phase 1 (1 trial), Phase 2 (8 trials), Phase 3 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ulcerative colitis clinical trial?
Eligibility criteria for ulcerative colitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 8
Phase 3 3
Phase 4 1
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05481619 Phase 4
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT07186101 Phase 2
Recruiting
Enrollment
252 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
NCT06865417 Phase 3
Recruiting
Enrollment
80 pts
Location
Belgium, Croatia, Fr...
Sponsor
Alfasigma S.p.A.
NCT07724990
Recruiting
Enrollment
20 pts
Location
Italy
Sponsor
Catholic University of the Sac...
NCT06228352
Recruiting
Enrollment
80 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT03615690
Recruiting
Enrollment
75 pts
Location
United States
Sponsor
Stanford University
NCT05218850 Phase 2
Recruiting
Enrollment
10 pts
Location
United States
Sponsor
Children's Hospital Los Angele...
NCT07619547
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
National Institute of Diabetes...
NCT03589183
Recruiting
Enrollment
1,500 pts
Location
South Korea
Sponsor
Kyunghee University Medical Ce...
NCT05327790 Phase 2
Recruiting
Enrollment
40 pts
Location
Canada
Sponsor
University of Alberta
NCT06515210
Recruiting
Enrollment
69 pts
Location
Canada
Sponsor
University of Alberta
NCT05743374
Recruiting
Enrollment
70 pts
Location
Sweden
Sponsor
Region Skane
NCT07064707 Phase 2
Recruiting
Enrollment
60 pts
Location
Egypt
Sponsor
Alexandria University
NCT04924270 Phase 2
Recruiting
Enrollment
200 pts
Location
Denmark
Sponsor
Odense University Hospital
NCT06780683
Recruiting
Enrollment
174 pts
Location
China
Sponsor
Xiang Gao
NCT05230173
Recruiting
Enrollment
216 pts
Location
United States
Sponsor
Mayo Clinic
NCT07513181 Phase 2
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Athos Therapeutics Inc
NCT06420492 Phase 2
Recruiting
Enrollment
20 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT04331639
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT03816345 Phase 1
Recruiting
Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
NCT03804931 Phase 2, Phase 3
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Guangzhou First People's Hospi...
NCT06937086 Phase 3
Recruiting
Enrollment
350 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
NCT06335160
Recruiting
Enrollment
46 pts
Location
Egypt
Sponsor
Tanta University
Related Conditions
crohn disease (6) inflammatory bowel disease (5) crohn s disease (2) inflammatory bowel diseases (2) rheumatoid arthritis (2) psoriatic arthritis (2) diet modification (1) diet habit (1) microbial colonization (1) ankylosing spondylitis (1) autoimmune diseases (1) ulcerative colitis chronic moderate (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology